tryptophan has been researched along with telbivudine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allison, WT; Blinov, N; Bratvold, J; Cashman, NR; DuVal, MG; Hinge, VK; Kanyo, R; Kovalenko, A; Pokrishevsky, E; Snyder, N | 1 |
1 other study(ies) available for tryptophan and telbivudine
| Article | Year |
|---|---|
Tryptophan 32 mediates SOD1 toxicity in a in vivo motor neuron model of ALS and is a promising target for small molecule therapeutics.
Topics: Amyotrophic Lateral Sclerosis; Animals; Humans; Motor Neurons; Nucleic Acid Synthesis Inhibitors; Superoxide Dismutase-1; Telbivudine; Tryptophan; Zebrafish | 2019 |